Metabolic Activation of Pirfenidone Mediated by Cytochrome P450s and Sulfotransferases.
Journal
Journal of medicinal chemistry
ISSN: 1520-4804
Titre abrégé: J Med Chem
Pays: United States
ID NLM: 9716531
Informations de publication
Date de publication:
13 08 2020
13 08 2020
Historique:
pubmed:
10
7
2020
medline:
26
11
2020
entrez:
10
7
2020
Statut:
ppublish
Résumé
Pirfenidone is approved for the treatment of idiopathic pulmonary fibrosis. Idiosyncratic drug reactions, due to clinical application of pirfenidone, have been documented, even along with death cases resulting from acute liver failure. The present study aimed at the investigation of metabolic activation of pirfenidone possibly participating in the reported adverse reactions. Pirfenidone-derived glutathione/
Identifiants
pubmed: 32643929
doi: 10.1021/acs.jmedchem.9b02073
doi:
Substances chimiques
Anti-Inflammatory Agents, Non-Steroidal
0
Pyridones
0
Cytochrome P-450 Enzyme System
9035-51-2
pirfenidone
D7NLD2JX7U
Sulfotransferases
EC 2.8.2.-
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM